DrSherazMarkar

Faculty of Medicine, Department of Surgery & Cancer

Honorary Clinical Senior Lecturer

Contact

+44 (0)20 3312 7657s.markar

Location

Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

Summary

From 2013 to 2016, I was awarded doctoral research fellowship by the National Institute for Health Research (NIHR) in the United Kingdom, through which I undertook my first PhD at Imperial College London. The subject was basic science focusing on non-invasive breath analysis of volatile organic compounds (breath test) for the diagnosis of gastro-intestinal cancer. From 2015 to 2018 I undertook my second PhD at Karolinska Institutet in Sweden, through which I developed further knowledge in clinical research in the surgical treatment of oesophageal cancer.

In 2016, I was awarded my first postdoctoral position with a NIHR Clinical Trials fellowship, to support my training in the design and conduct of randomised clinical trials /RCTs) at Imperial College London. Through this fellowship I was also able to work on an RCT comparing minimally invasive with open surgery for oesophageal cancer, which was published in New England Journal of Medicine. In 2017 I was appointed as NIHR Clinical Lecturer in Oesophago-Gastric Surgery at Imperial College London. The focus of my research became cancer survivorship, through which I coordinated three large multi-center European studies with recruitment of over 1000 oesophageal cancer survivors. I also continued my basic science research in breath test analysis as supervisor of PhD students, studying breath profiling of early oesophageal cancer and its premalignant lesion (Barrett’s oesophagus).

Publications

Journals

Challine A, Kirouani M, Markar SR, et al.Challine A, Kirouani M, Markar SR, Tzedakis S, Jaquet R, Piessen G, Dabakoyo-Yonli TS, Lefèvre JH, Lazzati A, Voron T close, 2024, MIRO study: Do the results of a randomized controlled trial apply in a real population?, Surgery, Vol:175, Pages:1055-1062

Down B, Lakunina S, Maynard N, et al.Down B, Lakunina S, Maynard N, Markar SR, Gordon-Weeks A close, 2024, Oncological outcomes of patients with oligometastatic oesophagogastric cancer., Eur J Surg Oncol, Vol:50

Chidambaram S, Markar SR, 2024, Epidemiology of Esophageal Squamous Cell Carcinoma, Foregut, Vol:4, Pages:65-71

Markar SR, Visser MR, van der Veen A, et al.Markar SR, Visser MR, van der Veen A, Luyer MDP, Nieuwenhuijzen G, Stoot JHMB, Tegels JJW, Wijnhoven BPL, Lagarde SM, de Steur WO, Hartgrink HH, Kouwenhoven EA, Wassenaar EB, Draaisma WA, Gisbertz SS, van Berge Henehouwen MI, van der Peet DL, Ruurda JP, van Hillegersberg R, LOGICA Study Group, Dutch Upper Gastrointestinal Cancer Audit Group close, 2024, Evolution in Laparoscopic Gastrectomy From a Randomized Controlled Trial Through National Clinical Practice., Ann Surg, Vol:279, Pages:394-401

Cizmic A, Romic I, Balla A, et al.Cizmic A, Romic I, Balla A, Barabino N, Anania G, Baiocchi GL, Bakula B, Balagué C, Berlth F, Bintintan V, Bracale U, Egberts J-H, Fuchs HF, Gisbertz SS, Gockel I, Grimminger P, van Hillegersberg R, Inaki N, Immanuel A, Korr D, Lingohr P, Mascagni P, Melling N, Milone M, Mintz Y, Morales-Conde S, Moulla Y, Müller-Stich BP, Nakajima K, Nilsson M, Reeh M, Sileri P, Targarona EM, Ushimaru Y, Kim Y-W, Markar S, Nickel F, Mitra AT close, 2024, An international Delphi consensus for surgical quality assessment of lymphadenectomy and anastomosis in minimally invasive total gastrectomy for gastric cancer., Surg Endosc, Vol:38, Pages:488-498

More Publications